Intelligence Β· Clinical Development
Pipeline search results
Programs matching βmonoclonalβ across our ClinicalTrials.gov index β phase, modality, sponsor, and trial IDs.
Quick answer
Showing 32 pipeline programs matching "monoclonal" from NovaPharmaNews Clinical Development Intelligence β phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Anti-human CCL24 monoclonal antibody (CM-101) - Part One
Chemomab Therapeutics
Nonalcoholic Fatty Liver Disease
1 trial -
BCSW-LDP+CDP1-β -01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Malignant Tumor
1 trial -
Humanized TNFΞ± monoclonal antibody
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Jasper Therapeutics
MYELODYSPLASTIC SYNDROME; MDS
1 trial -
Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial -
anti-EGFR monoclonal antibody
Dragonboat Biopharmaceutical Company Limited
Healthy Volunteers
1 trial -
monoclonal antibody M-T412
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs β not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars β improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes β use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.